• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MPRI VECTRIS SURESCAN; STIMULATOR, SPINAL-CORD, IMPLANTED (PAIN RELIEF)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MPRI VECTRIS SURESCAN; STIMULATOR, SPINAL-CORD, IMPLANTED (PAIN RELIEF) Back to Search Results
Model Number 977A275
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Erythema (1840); Fever (1858); Unspecified Infection (1930); Pain (1994); Chills (2191); Discomfort (2330); Sweating (2444)
Event Date 03/01/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received by a manufacture representative (rep) regarding a trial patient with an external neurostimulator for an unknown indication for use.(cervical trial) it was reported that the patient was experiencing fever, chills, sweating and stated that the area where the trial lead was placed was red and sore.It was unknown if there were any contributing factors.It was reported that the patient had had a spinal cord stimulator (scs) trial and a few days after the lead pull, the patient was experiencing pain.The patient went to the hospital and stated that they found an abscess in the epidural space.It was reported that no actions were taken at the time of the reported and it was unknown if the issue was resolved.The rep indicated that they had no further information but would be following up with the healthcare provider (hcp) for more information.It was indicated that the trial began on (b)(6) 2019 and the lead pull was (b)(6) 2019.The customer discarded the lead so it would not be returned for analysis.It was indicated that this was a cervical scs trial.The infection occurred after the scs trial ((b)(6) 2019,post-op).No further complications were reported/anticipated.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a healthcare provider (hcp) reporting that the patient began their trial on (b)(6) and returned on (b)(6) with good coverage and wanted to go forward with the permanent implant.On (b)(6) the patient called the hcp complaining of redness of the skin, pain in the mid to low back of the insertion point and sweats overnight.The hcp told the patient to got to the er (emergency room) and the patient went.Later that day (b)(6), the hcp spoke with the patient and due to their history of (b)(6) and infections in the past they started them on vancomycin.Later that day the patient was admitted for an ¿id workup¿.On (b)(6) 2019 the patient left.It was reported that they had been on antibiotics.The hcp then told them to go back to the hospital and the patient went for a treatment.When they were in the hospital they received antibiotics, and no surgical intervention was ever recommended or performed.The patient was feeling better and was discharged on (b)(6) 19 with a picc line and antibiotic regimen that a home nurse helped them take their daily.It was reported that the patient has now finished their course of antibiotics and was symptoms free for the past few months.Their abscess was resolved and they were not symptomatic.The patient still plans to go forward with the permanent placement.The patient¿s address and phone number were also reported.No further complications were reported/anticipated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VECTRIS SURESCAN
Type of Device
STIMULATOR, SPINAL-CORD, IMPLANTED (PAIN RELIEF)
Manufacturer (Section D)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer (Section G)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key8417419
MDR Text Key138689021
Report Number2649622-2019-04296
Device Sequence Number1
Product Code GZB
UDI-Device Identifier00763000006525
UDI-Public00763000006525
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P840001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/13/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/04/2022
Device Model Number977A275
Device Catalogue Number977A275
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received07/09/2019
Date Device Manufactured12/04/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age50 YR
-
-